Related Experiment Video
Updated: Nov 7, 2025

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Common virulence gene expression in adult first-time infected malaria patients and severe cases
J Stephan Wichers1,2,3, Gerry Tonkin-Hill4, Thorsten Thye5
1Molecular Biology and Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Abstract:
Sequestration of Plasmodium falciparum(P. falciparum)-infected erythrocytes to host endothelium through the parasite-derived P. falciparum erythrocyte membrane protein 1 (PfEMP1) adhesion proteins is central to the development of malaria pathogenesis. PfEMP1 proteins have diversified and expanded to encompass many sequence variants, conferring each parasite a similar array of human endothelial receptor-binding phenotypes. Here, we analyzed RNA-seq profiles of parasites isolated from 32 P. falciparum-infected adult travellers returning to Germany. Patients were categorized into either malaria naive (n = 15) or pre-exposed (n = 17), and into severe (n = 8) or non-severe (n = 24) cases. For differential expression analysis, PfEMP1-encoding var gene transcripts were de novo assembled from RNA-seq data and, in parallel, var-expressed sequence tags were analyzed and used to predict the encoded domain composition of the transcripts. Both approaches showed in concordance that severe malaria was associated with PfEMP1 containing the endothelial protein C receptor (EPCR)-binding CIDRα1 domain, whereas CD36-binding PfEMP1 was linked to non-severe malaria outcomes. First-time infected adults were more likely to develop severe symptoms and tended to be infected for a longer period. Thus, parasites with more pathogenic PfEMP1 variants are more common in patients with a naive immune status, and/or adverse inflammatory host responses to first infections favor the growth of EPCR-binding parasites.
Insights
Severe malaria is linked to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) binding the endothelial protein C receptor (EPCR). Non-severe cases involve CD36-binding PfEMP1, particularly in malaria-naive individuals.
Area of Science:
- Malariology
- Immunology
- Genomics
Background:
- Sequestration of Plasmodium falciparum-infected erythrocytes via PfEMP1 proteins drives malaria pathogenesis.
- PfEMP1 proteins exhibit diverse variants, influencing parasite binding to human endothelial receptors.
Purpose of the Study:
- To investigate the association between PfEMP1 variants and malaria severity in adult travelers.
- To correlate specific PfEMP1 binding phenotypes with clinical outcomes in Plasmodium falciparum infections.
Main Methods:
- RNA-sequencing (RNA-seq) analysis of Plasmodium falciparum isolates from 32 infected travelers.
- De novo assembly of PfEMP1-encoding var gene transcripts and analysis of var-expressed sequence tags.
- Categorization of patients based on malaria exposure (naive vs. pre-exposed) and disease severity (severe vs. non-severe).
Main Results:
- Severe malaria cases were associated with PfEMP1 variants binding the endothelial protein C receptor (EPCR).
- Non-severe malaria outcomes correlated with CD36-binding PfEMP1 variants.
- First-time infected adults were more prone to severe symptoms and longer infection duration.
Conclusions:
- Parasites expressing pathogenic PfEMP1 variants, particularly EPCR-binding types, are more prevalent in malaria-naive patients.
- Adverse inflammatory responses during initial infections may favor the proliferation of EPCR-binding Plasmodium falciparum strains.
- Understanding PfEMP1-receptor interactions is crucial for predicting and managing malaria severity.

